Viemed Healthcare (CVE:VMD) has been assigned a C$12.00 target price by stock analysts at Acumen Capital in a research note issued to investors on Friday, BayStreet.CA reports. The brokerage currently has a “buy” rating on the stock.

Viemed Healthcare has a 52-week low of C$1.65 and a 52-week high of C$5.09.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc, through its subsidiaries, provides in-home health care solutions in the United States. It offers respiratory services and related equipment, including non-invasive ventilators, positive airway pressure machines, and oxygen units, as well as services of respiratory therapists. The company also provides in-home sleep apnea testing to determine the existence of sleep apnea at home.

Featured Story: How to read a candlestick chart

Receive News & Ratings for Viemed Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viemed Healthcare and related companies with's FREE daily email newsletter.